Cargando…
[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer
Autores principales: | Wu, Lei, Wang, Tianyi, He, Dongning, Li, Xiaoxi, Jiang, Youhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619127/ https://www.ncbi.nlm.nih.gov/pubmed/37830162 http://dx.doi.org/10.3892/mmr.2023.13112 |
Ejemplares similares
-
EVI-1 acts as an oncogene and positively regulates calreticulin in breast cancer
por: Wu, Lei, et al.
Publicado: (2019) -
miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1
por: Wu, Lei, et al.
Publicado: (2018) -
Ecotropic virus integration-1 and calreticulin as novel prognostic markers in triple-negative breast cancer: A retrospective cohort study
por: He, Dongning, et al.
Publicado: (2019) -
Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retraction for Lectin-deficient Calreticulin Retains Full Functionality as a Chaperone for Class I Histocompatibility Molecules
Publicado: (2016)